US Patent 7951919 TACI-immunoglobulin fusion proteins

Patent 7951919 was granted and assigned to ZymoGenetics on May, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

ZymoGenetics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

79519190

Patent Inventor Names

Mark W. Rixon0

Jane A. Gross0

Date of Patent

May 31, 2011

Patent Application Number

126122880

Date Filed

November 4, 2009

Patent Primary Examiner

‌

David J Blanchard

Patent abstract

Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.